Orphan Drug

Drugs that are not developed by the pharmaceutical industry for economic reasons but which respond to public health need. Orphan drugs' are intended to treat diseases so rare that sponsors are reluctant to develop them under regular marketing conditions. The process from the discovery of a new molecule to its marketing is long, expensive and very uncertain. Developing a drug expecting to treat a rare disease does not allow the recovery of the capital invested for its research.

 

    Related Conference of Orphan Drug

    January 21-22, 2021

    7th Rare Diseases and Orphan Drugs

    Vienna, Austria
    February 15-16, 2021

    8th International Congress on Infectious Diseases

    London, UK
    May 10-11, 2021

    4th Global Experts Meeting on Infectious Diseases

    Singapore City, Singapore
    August 16-17, 2021

    13th Global Infections Conference

    Tokyo, Japan
    September 06-07, 2021

    11th World Congress on Rare Diseases and Orphan Drugs

    Berlin, Germany

    Orphan Drug Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in